Updates

“DOSE OF REALITY” | Calling Big Pharma’s Bluff On PBMs: Part V

Apr 9, 2019

Big Pharma has tried to evade culpability for the crisis of rising Read More

CSRxP Encourages Ways & Means Lawmakers To Advance Prescription Drug STAR Act

Apr 8, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part IV

Apr 8, 2019

Big Pharma has tried to evade culpability for the crisis of rising Read More

CSRxP: New Study Underscores Big Pharma The Only Rebate Rule Winner

Apr 8, 2019

Avalere Health Finds Proposed Rule Could Hike Premiums 40 Percent Read More

“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part III

Apr 7, 2019

Big Pharma has tried to evade culpability for the crisis of rising Read More

Second Opinion: Rebate Rule Would be Revolutionary … For Big Pharma

Apr 5, 2019

Nothing in Proposed Rule Guarantees Prices Will Come Down by Full Amount of Read More

“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part II

Apr 5, 2019

Big Pharma has tried to evade culpability for the crisis of rising Read More

“DOSE OF REALITY”  Calling Big Pharma’s Bluff On PBMs: Part I

Apr 4, 2019

Big Pharma has tried to evade culpability for the crisis of rising Read More

Bipartisan Advancement Of Key Drug Pricing Bills Signals A Coming Victory For American Patients

Apr 4, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

THEY SAID IT! Lawmakers Blast Insulin Price Hikes, Call For Drug Price Action And Question The Rebate Rule

Apr 3, 2019

On Tuesday, the U.S. House Committee on Energy and Commerce Subcommittee on Read More

CSRxP Encourages House Lawmakers To Advance Bipartisan Drug Pricing Legislation

Apr 2, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

Insulin Hearing Will Add To Drug Pricing Momentum On Capitol Hill 

Apr 1, 2019

CSRxP Commends House Energy & Commerce Committee For Giving Voice To Read More